MicroRNA-21 Inhibition Enhances In Vitro Chemosensitivity of Temozolomide-resistant Glioblastoma Cells
Anticancer Research, 07/05/2012
Clinical Article
Wong STS et al. – MiR–21 may have a potential for use as a biomarker of acquired temozolomide (TMZ) resistance. MiR–21 inhibition can be further explored as a potential chemotherapy adjunct in the treatment of TMZ–resistant glioblastoma multiforme (GBM).
